Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Celldex Therapeutics buy Cantor Fitzgerald

Start price
€23.80
03.11.23 / 50%
Target price
€48.43
03.11.24
Performance (%)
61.34%
Price
€38.40
08.05.24
Summary
This prediction is currently active. With a performance of 61.34% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 03.11.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Celldex Therapeutics 0.524% 0.524%
iShares Core DAX® 4.094% 3.543%
iShares Nasdaq 100 1.424% 0.512%
iShares Nikkei 225® -1.572% -4.633%
iShares S&P 500 1.822% 0.963%

Comments by Cantor_Fitzgerald for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) 61.34%
Target price 48.433
Change
Ends at 03.11.24

Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its price target lowered by analysts at Cantor Fitzgerald from $54.00 to $52.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€38.80
22.03.24
€61.99
22.03.25
-1.03%
08.05.24

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€25.00
12.10.23
€51.15
12.10.24
51.20%
08.05.24

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€25.80
27.09.23
€51.25
27.09.24
46.51%
08.05.24

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€27.80
16.08.23
€49.46
16.08.24
38.13%
08.05.24